Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8225630 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
DVH parameters of duodenum may predict Grade 3 GI toxicity after GemRT for LAPC. Concurrent use of erlotinib during GemRT may increase GI toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jiayi M.D., John M. M.D., Hong M.S., Jeffrey M.D., Laura M.D., Di D.Sc.,